(Adds CEO comments, details on Pfizer strategy, drug sales). By Ransdell Pierson. July 29 (Reuters) - Pfizer Inc, which in May abandoned its $118 billion bid to buy AstraZeneca Plc, on Tuesday left investors guessing whether it would renew its pursuit of its ...
Pfizer CEO Still Hunting for Deals and Willing to Go Big
Pfizer beats forecasts as oncology drugs grow
Related articles »